$heff's $tation of $tocks & $olid DD

[crudeoil24]

ONCE >>> Spark Therapeutics > The buzz around ONCE stemmed in part from its potential to receive the first-ever FDA approval for a gene therapy product, according to one fund manager. ONCE shares opened at $45.10, 96% above their IPO price. They're recently traded at $42.14. ([e-mail])
(END) Dow Jones Newswires

January 30, 2015 11:55 ET (16:55 GMT)